To be held in Arezzo, Italy, on October 18-19, 2012.
Personalized medicine is the future. Itâs where the science is going. Itâs where the technology is going. Itâs where doctors and patients will want to go. Yet, unfortunately for many of us, this is not where the Obama administration wants to go.
The September, 2012, edition of the Kidney Cancer Association's monthly video magazine includes a story about how depression affects cancer survival, along with a presentation by StÃ©phane Oudard, MD, PhD, "Vaccines in the Era of TKI: Much Ado About Nothing?"
People who take calcium supplements could be increasing their risk of having a heart attack, according to researchers in Germany.
Pfizer (PFE) is at a transformational point in its history. The company, which is the largest drug manufacturer in the world, is now splitting up and downsizing.
e-Therapeutics plc (AIM: ETX) announces that it has started a second phase I clinical trial of its anti-cancer drug ETS2101. This trial will enrol up to 45 patients with a variety of solid tumours...
Nichols's battle is part of a revolution in cancer treatment that has swept the field in the past two years.
âWould longer drug patents really lead to lower drug prices?â
My mother's recent diagnosis of kidney cancer was quickly followed by a recommendation to surgically remove the 7 centimeter tumor that is located on her right (and only) kidney.
People in Glasgow, Scotland die younger than people everywhere else in Britain and we donât know why.